Ras Al Khaimah (UAE) –Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced that the company’s exports to Bahrain and Kuwait will resume again. The announcement comes after the successful inspection of Julphar’s manufacturing facilities by the Gulf Health Council (GHC) and the Pharmaceutical & Herbal Medicine Registration & Quality Control Admin, Ministry of Health, State of Kuwait.
His Highness Sheikh Saqer Humaid Al Qasimi, Chairman of the Board, Julphar, said: “We are very pleased to announce that, once again, more than 100 products will be registered and available within Bahrain and Kuwait. We would like to extend our thanks to the authorities for their continued guidance and support during our collaboration to implement further improvements in our manufacturing processes as per the recommendations highlighted in their report. We look forward to being able to serve patients in both countries once again, as well as further bolstering our long-standing relationships and efforts with all relevant Bahraini, Kuwaiti and regional authorities as our products continue to be successfully sold here and in 50 markets around the world.”
Commenting on the lift, Dr. Essam Farouk, Chief Executive Officer at Julphar, said:
In 2019, Julphar began its operational transformation including an internal restructure and a cutting-edge revamp of all quality processes. This included a key focus on the company’s quality assurance, regulatory and development activities steered by over 200 scientists, medical professionals and regulatory experts to ensure Julphar delivers impactful and accessible healthcare solutions that respond to the needs of people and governments across the region and beyond.
© Press Release 2020